(Q44665635)

English

Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study

scientific article published in November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Isao Ikemoto

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hiroshi Kiyota

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yukihiko Ohishi

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Kazuhiro Abe

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hirokazu Goto

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Kouichi Kishimoto

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Kenta Miki

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

587-594

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

High prevalence of benign prostatic hypertrophy in the community

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00712.X

21 January 2018

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00712.X

21 January 2018

Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00712.X

21 January 2018

Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00712.X

21 January 2018

Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00712.X

21 January 2018

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00712.X

21 January 2018

Identifiers

10.1046/J.1442-2042.2003.00712.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44665635&oldid=2098829278"